Athanor Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-216,370
Closed -$2.11M 5
2022
Q1
$2.11M Sell
216,370
-123,030
-36% -$1.2M 2.88% 13
2021
Q4
$3.31M Sell
339,400
-10,600
-3% -$103K 2.39% 17
2021
Q3
$3.4M Hold
350,000
0.45% 60
2021
Q2
$3.4M Buy
+350,000
New +$3.43M 0.12% 121

Other funds holding AONC

Athanor Capital's AONC Position: Q2 2022 in Review

Athanor Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q2 2022, closing a stake of 216,370 shares — an estimated $2.11M sold.

Athanor Capital first reported a position in AONC in Q2 2021 and held it in 4 quarters. The position peaked at $3.4M in Q3 2021. 71 funds tracked by Wall St. Rank hold AONC as of Q2 2022.

  • Athanor Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Athanor Capital sold 216,370 American Oncology Network, Inc. Class A Common Stock shares in Q2 2022, an estimated $2.11M.
  • Athanor Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 4 quarters.
  • Athanor Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $3.4M in Q3 2021.
  • 71 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q2 2022.

Based on Athanor Capital's 13F filing for Q2 2022, filed 11 Aug 2022.